Form 4 filed by Kunkel Lori Anne
Kunkel Lori Anne filed this Form 4 on ELVN (Enliven Therapeutics, Inc.) with 4 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 22:21:24 UTC.
- Accession
- 0001536368-26-000008
- Filer
- CIK 1536368
- Filed
- 2026-11-03
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ELVN · Enliven Therapeutics, Inc. (CIK 1672619)
- Kunkel Lori Anne director
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-30 | M exercised | +3,741 | $1.12 | 45,625 | D |
| Common Stock | 2026-10-30 | M exercised | +7,300 | $18.3 | 52,925 | D |
| Stock Option (right to buy) derivative | 2026-10-30 | M exercised | -3,741 | $0 | 0 | D |
| Stock Option (right to buy) derivative | 2026-10-30 | M exercised | -7,300 | $0 | 30,582 | D |